Trending Topic

Human Internal Digestive Organs Pancreas with Gallbladder Anatomy
17 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Article Highlights Early use of sodium–glucose co-transporter-2 inhibitors following myocardial infarction was associated with the following factors: Lower hospitalization for heart failure (odds ratio [OR]: 0.75; 95% confidence interval [CI]: 0.62–0.90; p=0.002). Similar cardiovascular deaths (OR: 1.04; 95% CI: 0.83–1.30; p=0.76). Similar all-cause mortality (OR: 1.00; 95% CI: 0.82–1.21; p=0.98). Similar risks of ketoacidosis, acute […]

John Doupis: ADA 83rd Scientific Sessions, 2023: Type 2 diabetes highlights

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Aug 15th 2023

Dr. John Doupis (Director, Iatriko Paleou Falirou Medical Center, Diabetes Division, Athens, Greece; Editor-in-Chief, touchREVIEWS in Endocrinology) provides his top three highlights from the ADA 83rd Scientific Sessions, 2023 in the field of type 2 diabetes.

Disclosures: John Doupis has received consultant fees from Elli Lilly, Novo Nordisk, Abbott, Astra Zeneca and Boehringer Ingelheim. He has received grant/research support from Elli Lilly, Novo Nordisk and Boehringer Ingelheim. On the advisory board for Elli Lilly, Novo Nordisk, Abbott, Astra Zeneca and Boehringer Ingelheim. He has received honoraria/honorarium from Elli Lilly, Novo Nordisk, Abbott, Astra Zeneca and Boehringer Ingelheim. He is a Speaker’s Bureau participant with Elli Lilly, Novo Nordisk, Abbott, Astra Zeneca and Boehringer Ingelheim.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Sophie Nickelson.

Filmed as a highlight of ADA 2023.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup